JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomassen, D.
Right arrow Articles by Nelson, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomassen, D.
Right arrow Articles by Nelson, S. D.

Contribution of menthofuran to the hepatotoxicity of pulegone: assessment based on matched area under the curve and on matched time course

D Thomassen, JT Slattery and SD Nelson

Department of Pharmaceutics, University of Washington, Seattle.

In recent years it has become increasingly evident that the toxicity produced by a variety of compounds can be attributed to their metabolites. Simple dose-toxicity studies of a metabolite will help to elucidate its toxic effect, but it is not possible to quantify its role in the toxicity produced by the parent compound unless the disposition of the preformed and endogenously formed metabolite is taken into account. We assessed the contribution of the metabolite, R-(+)- menthofuran (MF), to the hepatotoxicity observed after i.p. administration of R-(+)-pulegone (PUL) to rats. As the major constituent of pennyroyal oil, PUL has been linked to the deaths of several young women over the past several years. After i.p. administration of PUL and MF to separate groups of rats at doses selected to match the area under the curve of generated and synthetic MF, plasma alanine transferase was comparable between groups. Although the area under the curve was matched, the peak concentration in plasma of MF formed in vivo is 4.5 times higher and occurs much earlier than after the administration of MF itself. When the exposure of rats to preformed and synthetic MF is matched with respect to time course in plasma, PUL produces more than twice the increase in plasma alanine transferase and hepatocellular necrosis than does MF. The results suggest that events other than those associated with the disposition of MF contribute to the hepatotoxicity observed after ingestion of PUL, and they emphasize the importance of time course in assessing the role of a metabolite in the toxicity of a given compound.

Volume 244, Issue 3, pp. 825-829, 03/01/1988
Copyright © 1988 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
L.-J. Chen, E. H. Lebetkin, and L. T. Burka
METABOLISM OF (R)-(+)-MENTHOFURAN IN FISCHER-344 RATS: IDENTIFICATION OF SULFONIC ACID METABOLITES
Drug Metab. Dispos., October 1, 2003; 31(10): 1208 - 1213.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
L.-J. Chen, E. H. Lebetkin, and L. T. Burka
Metabolism of (R)-(+)-Pulegone in F344 Rats
Drug Metab. Dispos., December 1, 2001; 29(12): 1567 - 1577.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
H. V. Thulasiram, V. B. Bhat, and M. K. Madyastha
Effect of Ring Size in R-(+)-Pulegone-Mediated Hepatotoxicity: Studies on the Metabolism of R-(+)-4-Methyl-2-(1-Methylethylidene)-Cyclopentanone and DL-Camphorone in Rats
Drug Metab. Dispos., June 1, 2001; 29(6): 821 - 829.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
M. Miyazawa, M. Shindo, and T. Shimada
Oxidation of 1,8-Cineole, the Monoterpene Cyclic Ether Originated From Eucalyptus Polybractea, by Cytochrome P450 3A Enzymes in Rat and Human Liver Microsomes
Drug Metab. Dispos., February 1, 2001; 29(2): 200 - 205.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
H. V. Thulasiram, A. K. Gadad, and M. K. Madyastha
Role of C-5 Chiral Center in R-(+)-Pulegone-Mediated Hepatotoxicity: Metabolic Disposition and Toxicity of 5,5-Dimethyl-2-(1-Methylethylidene)-Cyclohexanone in Rats
Drug Metab. Dispos., July 1, 2000; 28(7): 833 - 844.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
S. C. Khojasteh-Bakht, W. Chen, L. L. Koenigs, R. M. Peter, and S. D. Nelson
Metabolism of (R)-(+)-Pulegone and (R)-(+)-Menthofuran by Human Liver Cytochrome P-450s: Evidence for Formation of a Furan Epoxide
Drug Metab. Dispos., May 1, 1999; 27(5): 574 - 580.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
K. M. Madyastha and N. W. Gaikwad
Metabolic Disposition of a Monoterpene Ketone, Piperitenone, in Rats: Evidence for the Formation of a Known Toxin, p-cresol
Drug Metab. Dispos., January 1, 1999; 27(1): 74 - 80.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
S. C. Khojasteh-Bakht, L. L. Koenigs, R. M. Peter, W. F. Trager, and S. D. Nelson
(R)-(+)-Menthofuran Is a Potent, Mechanism-Based Inactivator of Human Liver Cytochrome P450 2A6
Drug Metab. Dispos., July 1, 1998; 26(7): 701 - 704.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1988 by the American Society for Pharmacology and Experimental Therapeutics.